Detalles MARC
| 000 -CABECERA |
| campo de control de longitud fija |
10031nam a22003613i 4500 |
| 001 - NÚMERO DE CONTROL |
| campo de control |
232320 |
| 003 - IDENTIFICADOR DEL NÚMERO DE CONTROL |
| campo de control |
ES-VaUE |
| 005 - FECHA Y HORA DE LA ÚLTIMA TRANSACCIÓN |
| campo de control |
20220608205547.0 |
| 006 - CÓDIGOS DE INFORMACIÓN DE LONGITUD FIJA--CARACTERÍSTICAS DEL MATERIAL ADICIONAL |
| campo de control de longitud fija |
m o d | |
| 007 - CAMPO FIJO DE DESCRIPCIÓN FÍSICA--INFORMACIÓN GENERAL |
| campo de control de longitud fija |
cr cnu|||||||| |
| 008 - DATOS DE LONGITUD FIJA--INFORMACIÓN GENERAL |
| campo de control de longitud fija |
211214s2022 xx o ||||0 eng d |
| 020 ## - NÚMERO INTERNACIONAL ESTÁNDAR DEL LIBRO |
| Número Internacional Estándar del Libro |
3030809323 |
| 040 ## - FUENTE DE LA CATALOGACIÓN |
| Centro catalogador/agencia de origen |
MiAaPQ |
| Lengua de catalogación |
eng |
| Normas de descripción |
rda |
| -- |
pn |
| Centro/agencia transcriptor |
UEV |
| Centro/agencia modificador |
MiAaPQ |
| 050 ## - SIGNATURA TOPOGRÁFICA DE LA BIBLIOTECA DEL CONGRESO |
| Número de clasificación |
R857 |
| Número de documento/Ítem |
.A268 2022 EB |
| 100 1# - ENTRADA PRINCIPAL--NOMBRE DE PERSONA |
| Nombre de persona |
About, Imad |
| 245 10 - MENCIÓN DE TÍTULO |
| Título |
Biodentine(tm) : |
| Resto del título |
Properties and Clinical Applications |
| 246 ## - FORMA VARIANTE DE TÍTULO |
| Título propio/Titulo breve |
Biodentine |
| 264 #1 - PRODUCCIÓN, PUBLICACIÓN, DISTRIBUCIÓN, FABRICACIÓN Y COPYRIGHT |
| Producción, publicación, distribución, fabricación y copyright |
Cham |
| Nombre del de productor, editor, distribuidor, fabricante |
Springer International Publishing AG |
| Fecha de producción, publicación, distribución, fabricación o copyright |
2022 |
| 300 ## - DESCRIPCIÓN FÍSICA |
| Extensión |
1 online resource (233 pages) |
| 336 ## - TIPO DE CONTENIDO |
| Término de tipo de contenido |
text |
| Código de tipo de contenido |
txt [ |
| Fuente |
rdacontent] |
| 337 ## - TIPO DE MEDIO |
| Nombre/término del tipo de medio |
computer |
| Código del tipo de medio |
c [ |
| Fuente |
rdamedia] |
| 338 ## - TIPO DE SOPORTE |
| Nombre/término del tipo de soporte |
online resource |
| Código del tipo de soporte |
cr [ |
| Fuente |
rdacarrier] |
| 505 0# - NOTA DE CONTENIDO CON FORMATO |
| Nota de contenido con formato |
Intro -- Acknowledgments -- Contents -- Contributors -- About the Editor -- Introduction -- 1: BiodentineTM Microstructure andComposition -- 1.1 Introduction -- 1.2 Presentation andMixing -- 1.3 Chemical Composition -- 1.3.1 Cement Base -- 1.3.2 Modifiers -- 1.4 Biodentine Microstructure -- 1.5 Conclusions -- References -- 2: BiodentineTM Physico-Chemical Properties: FromInteractions withDental Tissues toAgeing -- 2.1 Introduction -- 2.2 Properties oftheCement -- 2.2.1 The CSH Gel -- 2.2.1.1 Setting Time -- 2.2.1.2 Viscosity andFlowability -- 2.2.1.3 Porosity -- 2.2.2 The Ion-Rich Water (Pore Solution) -- 2.2.2.1 Water Sorption -- 2.2.2.2 Solubility -- 2.2.2.3 Pore Solution pH -- 2.2.2.4 Ca andSi Ions -- 2.3 Ageing andtheEffect ofCuring Environment onBiodentine -- 2.3.1 Phosphate-Rich Media -- 2.3.2 Carbonation andtheBicarbonate Ion -- 2.3.3 pH oftheSurrounding Environment -- 2.4 Biodentine inRelation toDentine -- 2.4.1 Interaction withSound Dentine -- 2.4.1.1 Tag-Like Structures -- 2.4.1.2 Structurally Altered Dentine Layer (Mineral Infiltration Zone) -- 2.4.2 Interaction withCarious or Demineralised Dentine -- 2.5 Conclusion -- References -- 3: Biocompatibility andBioactive Properties ofBiodentineTM -- 3.1 Introduction -- 3.2 Biocompatibility -- 3.2.1 Effects onTarget Cells Following Pulp Capping Procedures -- 3.2.2 Interaction withTooth-Surrounding Tissues -- 3.3 Effects ofBiodentine™ onPulp-Dentine Regeneration Potential -- 3.3.1 Biodentine™ Implication intheResolution ofInflammation -- 3.3.2 Biodentine™ Implication inNeoangiogenesis -- 3.3.3 Biodentine™ Induces Pulp Fibroblast Proliferation andRecruitment -- 3.3.4 Biodentine™ Enhances Dental Pulp Stem Cell Recruitment -- 3.3.5 Effects onDifferentiation andMineralization -- 3.3.5.1 In Vitro -- 3.3.5.2 In Vivo |
| 505 8# - NOTA DE CONTENIDO CON FORMATO |
| Nota de contenido con formato |
3.3.6 The Role ofHydration By-Products upon Setting -- 3.4 Osteogenic Potential -- 3.4.1 In Vitro -- 3.4.2 In Vivo -- 3.5 Conclusions -- References -- 4: BiodentineTM inInflammation andPain Control -- 4.1 Introduction -- 4.2 The Physiology ofPulpal Pain -- 4.2.1 Nerves -- 4.2.2 Odontoblasts -- 4.3 Odontoblasts andPulp Cells Express Functional Hot andCold Receptors -- 4.4 Pulpal Pain andInflammation -- 4.5 Biodentine Sealing andAntibacterial Potentials -- 4.6 Modulation ofPulpal Pain andInflammation by Biodentine: Evidence fromInVitro Studies -- 4.6.1 Biodentine Modulation ofPro- and Anti-inflammatory Molecules -- 4.6.2 Modulation ofInflammatory Cell Recruitment -- 4.7 Modulation ofInflammation: Evidence fromInVivo Studies -- 4.8 Modulation ofPulpal Pain by Biodentine: Evidence fromClinical Studies -- References -- 5: BiodentineTM Clinical Applications inVital Pulp Therapy inPermanent Teeth -- 5.1 Introduction -- 5.2 Histopathology ofCarious Dentine -- 5.3 Indirect Pulp Protection -- 5.3.1 One-Step Approach -- 5.3.2 Two-Step Approach -- 5.3.3 Materials Used forIndirect Pulp Protection -- 5.4 Biodentine™ -- 5.4.1 Pulp Protection andDentine Replacement (Table5.2) -- 5.5 Direct Pulp Protection -- 5.5.1 Direct Pulp Protection: Clinical Procedure -- 5.5.2 Partial/Full Pulpotomy: Clinical Procedure -- 5.5.3 Materials Used forDirect Pulp Protection -- References -- 6: BiodentineTM: Applications inPulpotomy ofDeciduous Teeth -- 6.1 Introduction -- 6.2 Pulpotomy inDeciduous Teeth -- 6.3 Deciduous vs. Permanent Tooth Pulp -- 6.4 Regenerative Potential ofDental Pulp -- 6.5 Interaction ofPulpotomy Materials withDentine-Pulp Complex -- 6.6 Materials Used inPulpotomy -- 6.7 Classification ofPulpotomy Medicaments -- 6.8 Efficacy ofBiodentine asaPulpotomy Medicament inDeciduous Teeth |
| 505 8# - NOTA DE CONTENIDO CON FORMATO |
| Nota de contenido con formato |
6.9 Biodentine vs. Formocresol -- 6.10 Biodentine vs. MTA -- 6.11 Biodentine vs. Other Pulpotomy Materials -- 6.12 Pulpotomy Procedure withBiodentine -- 6.13 Conclusion -- References -- 7: BiodentineTM Applications inTraumatology andFractures -- 7.1 Introduction -- 7.1.1 Paradigm Shift -- 7.1.2 Casuistics -- 7.1.3 Choice forBiodentine -- 7.2 Direct Pulp Capping inTraumatised Immature Incisors -- 7.2.1 Casuistics -- 7.3 Pulpotomy inTraumatised Immature Incisors -- 7.3.1 Casuistics -- 7.4 Full Obturation inTraumatised Incisors -- 7.4.1 Casuistics -- 7.4.1.1 Case 1: 9-Year-Old Girl withInfection of22 -- 7.4.1.2 Case 2: 8-Year-Old Girl withRecurrent Infection After Trauma of11 -- 7.5 Root Fractures -- 7.5.1 Casuistics -- 7.6 Save theUnsaved -- 7.6.1 Necrotic Immature Teeth After Trauma -- 7.6.1.1 Casuistics -- 7.6.2 Saving theUnsaved -- 7.6.2.1 Casuistics -- Case 1: 5-Year-Old Boy withaUnilateral Root Fracture ontheImmature Tooth 21 -- Case 2: 6-Year-Old Boy withaSevere Trauma onaFreshly Erupted Incisor -- 7.7 Conclusion -- References -- 8: BiodentineTM Applications inIrreversible Pulpitis Management inChildren andAdults -- 8.1 Pulpal Status Beneath Carious Exposures andtheClassification ofPulpitis -- 8.2 Diagnosis ofIrreversible Pulpitis andIts Limitations inChildren andAdults -- 8.2.1 Preoperative Clinical andRadiographic Examination -- 8.2.1.1 Signs andSymptoms -- 8.2.1.2 Sensibility Tests -- 8.2.1.3 Radiographic Examination -- 8.2.2 Intraoperative Assessment -- 8.3 Case Selection forVital Pulp Therapy inTeeth withIrreversible Pulpitis inChildren -- 8.3.1 Restorability oftheAffected Tooth andStage ofDeveloping Dentition -- 8.3.2 Incomplete Root Formation andThin Dentine Wall |
| 505 8# - NOTA DE CONTENIDO CON FORMATO |
| Nota de contenido con formato |
8.4 Is Vital Pulp Therapy aViable andEven Preferred Alternative toPulpectomy forTeeth withClinical Diagnosis ofIrreversible Pulpitis inChildren andAdults? -- 8.4.1 Does Age Matter inDecision-Making inVital Pulp Therapy? -- 8.4.2 Cost-Effectiveness ofVital Pulp Therapy -- 8.5 Outcome ofVital Pulp Therapy inTeeth withIrreversible Pulpitis inChildren andAdults -- 8.5.1 Coronal Pulpotomy -- 8.5.2 Partial Pulpotomy andMiniature Pulpotomy -- 8.5.3 Direct andIndirect Pulp Capping -- 8.6 Biodentine Applications inIrreversible Pulpitis Management -- 8.7 Which Irreversible Pulpitis Tooth Can BeaCandidate forVital Pulp Therapy inChildren andAdults? -- 8.8 Vital Pulp Therapy Using Biodentine inTeeth withIrreversible Pulpitis: Procedure -- 8.9 Outcome Measures forSuccessful Vital Pulp Therapy -- 8.10 Possible Complications Following Vital Pulp Therapy withBiodentine inTeeth withIrreversible Pulpitis -- 8.10.1 Pulp Necrosis andApical Periodontitis -- 8.10.2 Cervical Root Fracture -- 8.10.3 Pulp Canal Obliteration -- 8.11 Conclusions -- References -- 9: Calcium Silicate-Based Cement (BiodentineTM) asaBioactive Material fortheLong-Term Preservation ofPulp Vitality inRestorative Dentistry andProsthodontics -- 9.1 Introduction -- 9.2 Clinical Evidence ontheEfficacy ofBiodentine asanIDP or DPC Material inVital Pulp Therapy -- 9.3 Studies Evaluating IPC withBiodentine -- 9.4 Studies Evaluating DPC withBiodentine -- 9.5 Case Series -- 9.5.1 Clinical Case 1 -- 9.5.2 Clinical Case 2 -- 9.5.3 Clinical Case 3 -- 9.5.4 Clinical Case 4 -- 9.5.5 Clinical Case 5 -- 9.6 Discussion -- 9.6.1 Studies ofthePreservation ofPulp Vitality After IPC withBiodentine -- 9.6.2 Studies ofthePreservation ofPulp Vitality After DPC withBiodentine -- 9.7 Conclusions -- References |
| 505 8# - NOTA DE CONTENIDO CON FORMATO |
| Nota de contenido con formato |
10: BiodentineTM Applications inFurcation Perforation andRoot Resorption -- 10.1 Furcation Perforations -- 10.1.1 Repair ofFresh Perforations -- 10.1.2 Repair ofOld Perforations -- 10.1.3 Matrix Technique -- 10.1.4 Push-Out Bond Strength -- 10.1.5 Reactions ofCells ofthePeriodontium toBiodentine -- 10.1.5.1 Reactions ofCells ofthePeriodontium InVitro -- 10.1.5.2 Reactions ofCells ofthePeriodontium inRats -- 10.1.5.3 Reactions ofCells ofthePeriodontium inDogs -- 10.1.5.4 Reactions ofCells ofthePeriodontium inHumans -- 10.1.6 Advantages ofBiodentine intheRepair ofFurcation Perforations -- 10.2 Root Resorption -- 10.2.1 Internal Resorptions -- 10.2.2 Management ofInternal Resorption -- 10.2.3 External Resorptions -- 10.2.3.1 Replacement Resorption -- 10.2.3.2 Cervical Resorption -- 10.2.3.3 Transient Resorptions -- 10.2.4 Management ofExternal Resorption -- 10.2.5 Management ofExternal Cervical Resorption -- 10.2.6 Advantages ofBiodentine intheTreatment ofRoot Resorptions -- 10.2.6.1 Antiresorptive Effect ofBiodentine -- 10.2.6.2 Bioactivity andBiocompatibility ofBiodentine -- 10.2.6.3 Stabilization oftheTooth Structure Through Biodentine -- 10.3 Conclusion -- References -- 11: Clinical Application ofBiodentineTM inRegenerative Endodontics/Revitalization -- 11.1 Indication ofRevitalization Procedures -- 11.2 Clinical Procedure -- 11.2.1 First Visit: Disinfection -- 11.2.2 Second Visit: Intracanal Blood Clot Induction -- 11.3 Outcome -- 11.4 Material Selection -- 11.4.1 Irrigation andIntracanal Medicament -- 11.4.2 Hydraulic Calcium Silicate Cement -- 11.5 Regeneration andRepair -- 11.6 Future Perspectives -- 11.7 Conclusions -- References |
| 655 #4 - TÉRMINO DE INDIZACIÓN--GÉNERO/FORMA |
| Datos o término principal de género/forma |
Electronic books |
| 776 ## - ENTRADA/ENLACE A UN FORMATO FÍSICO ADICIONAL |
| Número Internacional Estándar del Libro |
3-030-80931-5 |
| 856 40 - LOCALIZACIÓN Y ACCESO ELECTRÓNICOS |
| Identificador Uniforme del Recurso |
https://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-80932-4 |
| Nota pública |
Acceso a este recurso digital (usuarios Universidad Europea de Valencia) |
| 942 ## - ELEMENTOS DE PUNTO DE ACCESO ADICIONAL (KOHA) |
| Fuente del sistema de clasificación o colocación |
Library of Congress Classification |
| Tipo de ítem Koha |
LIBRO-E NO PRÉSTAMO |
| 998 ## - DATOS ESTADÍSTICOS |
| Tipo de materia |
E-book |